<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04551105</url>
  </required_header>
  <id_info>
    <org_study_id>TaiHao BR-USCAD VT 20-249</org_study_id>
    <nct_id>NCT04551105</nct_id>
  </id_info>
  <brief_title>Evaluation of TaiHao Breast Ultrasound Diagnosis Software</brief_title>
  <official_title>Evaluation of TaiHao Breast Ultrasound Diagnosis Software</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TaiHao Medical Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taipei Veterans General Hospital, Taiwan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Virginia Polytechnic Institute and State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>TaiHao Medical Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The BR-USCAD DS Module is a computer-assisted detection and diagnosis software based on a&#xD;
      deep learning algorithm. This retrospective, fully-crossed, multi-reader, multi-case (MRMC)&#xD;
      study aims to compare the performances of readers without and with the aid of the Breast&#xD;
      Ultrasound Image Reviewed with Assistance of Computer-Assisted Detection and Diagnosis System&#xD;
      (BR-USCAD DS) in interpreting breast ultrasound images of lesions.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 15, 2020</start_date>
  <completion_date type="Anticipated">October 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MRMC AUC analysis</measure>
    <time_frame>15 Day</time_frame>
    <description>Area under the ROC curve. Value range: [0, 1]</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity</measure>
    <time_frame>2 Days</time_frame>
    <description>Sensitivity = TP/P, value range: [0, 1] Comparing to the reference standard, the sensitivity of breast imaging results by readers with BR-USCAD DS will be evaluated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specificity</measure>
    <time_frame>2 Days</time_frame>
    <description>Specificity = TN/N, value range: [0, 1] Comparing to the reference standard, the specificity of breast imaging results by readers with BR-USCAD DS will be evaluated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inter-rater reliability</measure>
    <time_frame>2 Days</time_frame>
    <description>Calculate Kappa result to evaluate the agreement between raters and system. The Kappa value could be interpreted as follows: values â‰¤ 0 as indicating no agreement and 0.01-0.20 as none to slight, 0.21-0.40 as fair, 0.41- 0.60 as moderate, 0.61-0.80 as substantial, and 0.81-1.00 as almost perfect agreement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reading time</measure>
    <time_frame>2 Days</time_frame>
    <description>Reading time in seconds. Measure reading time of breast imaging reporting and system lexicon value in breast imaging by readers without BR-USCAD DS for breast and also measured report time by readers with BR-USCAD DS for breast.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Breast Diseases</condition>
  <arm_group>
    <arm_group_label>First session: manual review first and then review with CADx</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each rater will interpret the &quot;Dataset A&quot; cases in different random order without any assistance of artificial assistance first, and then interpret the &quot;Dataset B&quot; cases in different random order with BR-USCAD DS.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>First session: review with CADx first and then manual review</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each rater will interpret the &quot;Dataset A&quot; cases in different random order with BR-USCAD DS first, and then interpret the &quot;Dataset B&quot; cases in different random order without any assistance of artificial assistance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Second session: manual review first and then review with CADx</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>At least 4 weeks after first session for memory washing out. Each rater will interpret the &quot;Dataset A&quot; cases in different random order without any assistance of artificial assistance first, and then interpret the &quot;Dataset B&quot; cases in different random order with BR-USCAD DS.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Second session: review with CADx first and then manual review</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>At least 4 weeks after first session for memory washing out. Each rater will interpret the &quot;Dataset A&quot; cases in different random order with BR-USCAD DS first, and then interpret the &quot;Dataset B&quot; cases in different random order without any assistance of artificial assistance.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Reader Group X</intervention_name>
    <description>Each rater in &quot;Reader Group X&quot; will interpret the &quot;dataset A&quot; cases in different random order without BR-USCAD DS and interpret the &quot;dataset B&quot; cases in different random order with BR-USCAD DS.</description>
    <arm_group_label>First session: manual review first and then review with CADx</arm_group_label>
    <arm_group_label>Second session: review with CADx first and then manual review</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Reader Group Y</intervention_name>
    <description>Each rater in &quot;Reader Group Y&quot; will interpret the &quot;dataset A&quot; cases in different random order with BR-USCAD DS and interpret the &quot;dataset B&quot; cases in different random order without BR-USCAD DS.</description>
    <arm_group_label>First session: review with CADx first and then manual review</arm_group_label>
    <arm_group_label>Second session: manual review first and then review with CADx</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  B-mode breast ultrasound image&#xD;
&#xD;
          -  Female, age 21 or older&#xD;
&#xD;
          -  Breast lesion images acquired before a biopsy or surgery - these images were&#xD;
             retrospectively collected with histology report.&#xD;
&#xD;
          -  Non-biopsied benign lesions with negative follow-up for a minimum of 12 months&#xD;
&#xD;
          -  At least two orthogonal views of a lesion&#xD;
&#xD;
          -  All the cases in this study are collected from at least 3 different ultrasound&#xD;
             apparatuses&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Breast lesion images acquired after biopsy or surgery.&#xD;
&#xD;
          -  Any breast surgeries or interventional procedures in the 12 months prior to ultrasound&#xD;
             imaging&#xD;
&#xD;
          -  Case demonstrating administrative or technical errors&#xD;
&#xD;
          -  Multiple lesions in one 2-D ultrasound image&#xD;
&#xD;
          -  Breast ultrasound images with Doppler, elastography, or other overlays present&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shih Chung Lo, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Arlington Innovation Center: Health Research - Virginia Tech</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Arlington Innovation Center: Health Research - Virginia Tech</name>
      <address>
        <city>Arlington</city>
        <state>Virginia</state>
        <zip>22203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 2, 2020</study_first_submitted>
  <study_first_submitted_qc>September 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2020</study_first_posted>
  <last_update_submitted>September 10, 2020</last_update_submitted>
  <last_update_submitted_qc>September 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

